Loading...
Therapeutic exon skipping for dysferlinopathies?
Antisense-mediated exon skipping is a promising therapeutic approach for Duchenne muscular dystrophy (DMD) currently tested in clinical trials. The aim is to reframe dystrophin transcripts using antisense oligonucleotides (AONs). These hide an exon from the splicing machinery to induce exon skipping...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2987387/ https://ncbi.nlm.nih.gov/pubmed/20145676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ejhg.2010.4 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|